Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Edward V. Loftus Jr."'
Autor:
Siddhant Yadav, Edward V. Loftus Jr., W. Scott Harmsen, Louis M. Wong Kee Song, Nayantara Coelho-Prabhu
Publikováno v:
Endoscopy International Open, Vol 07, Iss 08, Pp E994-E1001 (2019)
Background and study aims There are limited published data on endoscopic removal of colorectal polyps by endoscopic mucosal resection (EMR) and endoscopic mucosal dissection (ESD) in patients with inflammatory bowel disease (IBD). Patients and method
Externí odkaz:
https://doaj.org/article/0fa413df757847059e2c7218bdbd1c8a
Autor:
Moktan, Varun P., Daoud, Nader D., Tremaine, William J., Edward V., Loftus Jr., Kane, Sunanda V., Hochwald, Alexander P., Hodge, David O., Hashash, Jana G., Faubion, Stephanie S., Farraye, Francis A.
Publikováno v:
Crohn's & Colitis 360; Jul2022, Vol. 4 Issue 3, p1-3, 3p
Autor:
Edward V. Loftus Jr
By the time this issue of Gastroenterology Clinics of North America is released, it will have been 16 years since infliximab was approved by the US Food and Drug Administration for the treatment of moderate to severe Crohn disease. Not only have we c
Autor:
Edward V. Loftus Jr.
Publikováno v:
American Journal of Gastroenterology (Springer Nature); Jul2005, Vol. 100 Issue 7, p1435-1438, 4p
Autor:
Edward V. Loftus Jr.
Publikováno v:
Journal of Clinical Gastroenterology; May/Jun2003, Vol. 36 Issue 5, pS79, 5p
Autor:
Ioannis E. Koutroubakis, Simon Travis, Edward V. Loftus, Bruce E. Sands, Yehuda Chowers, Arthur Kaser, Antonino Spinelli, Maria T. Abreu, Gerassimos J. Mantzaris, Gerhard Rogler, Parambir S. Dulai, Milan Lukas, Dan Turner, Ailsa Hart, Colm O'Morain, Jonas Halfvarson, Matthieu Allez, Severine Vermeire, Silvio Danese, Geert R. D'Haens, William J. Sandborn, Walter Reinisch, Siew C. Ng, Subrata Ghosh, Flavio Steinwurz, Pia Munkholm, Jean-Frederic Colombel, Remo Panaccione, Stefan Schreiber, David B. Sachar, Laurent Peyrin-Biroulet, Julián Panés, Vipul Jairath, Aswhin N. Ananthakrishnan, Peter R. Gibson, Wolfgang Kruis, Catherine Le Berre, Iris Dotan, David T. Rubin
Publikováno v:
Gastroenterology
Gastroenterology, WB Saunders, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
Gastroenterology, 160(5), 1452-1460.e21. W.B. Saunders Ltd
Gastroenterology, Elsevier, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
Gastroenterology, WB Saunders, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
Gastroenterology, 160(5), 1452-1460.e21. W.B. Saunders Ltd
Gastroenterology, Elsevier, 2021, 160 (5), pp.1452-1460.e21. ⟨10.1053/j.gastro.2020.10.065⟩
International audience; Background and aims: Inflammatory bowel diseases (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), are chronic and disabling disorders. Prospective disease-modification trials to prevent disease progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdfd72625f12282fdbd4a9584309a3f3
https://doi.org/10.1053/j.gastro.2020.10.065
https://doi.org/10.1053/j.gastro.2020.10.065
Autor:
Lightner AL; Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota, United States., Edward V Loftus Jr; Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota, United States., McKenna NP; Division of Colon and Rectal Surgery, Mayo Clinic, Rochester, Minnesota, United States., Raffals LE; Division of Gastroenterology, Mayo Clinic, Rochester, Minnesota, United States.
Publikováno v:
Current drug targets [Curr Drug Targets] 2019; Vol. 20 (13), pp. 1317-1322.